Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Water maze testing to identify compounds for cognitive enhancement.

Rose GM, Rowe WB.

Curr Protoc Pharmacol. 2012 Dec;Chapter 5:Unit 5.63. doi: 10.1002/0471141755.ph0563s59.

PMID:
23258600
2.

Genomic and proteomic strategies to identify novel targets potentially involved in learning and memory.

Benoit CE, Rowe WB, Menard C, Sarret P, Quirion R.

Trends Pharmacol Sci. 2011 Jan;32(1):43-52. doi: 10.1016/j.tips.2010.10.002. Epub 2010 Dec 2. Review.

PMID:
21129790
3.

RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents.

Wallace TL, Callahan PM, Tehim A, Bertrand D, Tombaugh G, Wang S, Xie W, Rowe WB, Ong V, Graham E, Terry AV Jr, Rodefer JS, Herbert B, Murray M, Porter R, Santarelli L, Lowe DA.

J Pharmacol Exp Ther. 2011 Jan;336(1):242-53. doi: 10.1124/jpet.110.171892. Epub 2010 Oct 19.

PMID:
20959364
4.

Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats.

Rowe WB, Blalock EM, Chen KC, Kadish I, Wang D, Barrett JE, Thibault O, Porter NM, Rose GM, Landfield PW.

J Neurosci. 2007 Mar 21;27(12):3098-110.

5.

Neurotensin receptor levels as a function of brain aging and cognitive performance in the Morris water maze task in the rat.

Rowe WB, Kar S, Meaney MJ, Quirion R.

Peptides. 2006 Oct;27(10):2415-23. Epub 2006 Jul 26.

PMID:
16872718
6.
7.

Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats.

Rowe WB, O'Donnell JP, Pearson D, Rose GM, Meaney MJ, Quirion R.

Behav Brain Res. 2003 Oct 17;145(1-2):171-8.

PMID:
14529815
8.

Theta-frequency synaptic potentiation in CA1 in vitro distinguishes cognitively impaired from unimpaired aged Fischer 344 rats.

Tombaugh GC, Rowe WB, Chow AR, Michael TH, Rose GM.

J Neurosci. 2002 Nov 15;22(22):9932-40.

9.

Effects of hippocampal lesions on patterned motor learning in the rat.

Gould TJ, Rowe WB, Heman KL, Mesches MH, Young DA, Rose GM, Bickford PC.

Brain Res Bull. 2002 Sep 30;58(6):581-6.

PMID:
12372562
10.

Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats.

Yau JL, Noble J, Hibberd C, Rowe WB, Meaney MJ, Morris RG, Seckl JR.

J Neurosci. 2002 Feb 15;22(4):1436-42.

11.

A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus.

Barditch-Crovo P, Noe D, Skowron G, Lederman M, Kalayjian RC, Borum P, Buier R, Rowe WB, Goldberg D, Lietman P.

J Clin Pharmacol. 1998 Apr;38(4):357-63.

PMID:
9590463
12.

An elemental diet containing medium-chain triglycerides and enzymatically hydrolyzed protein can improve gastrointestinal tolerance in people infected with HIV.

Salomon SB, Jung J, Voss T, Suguitan A, Rowe WB, Madsen DC.

J Am Diet Assoc. 1998 Apr;98(4):460-2. No abstract available.

PMID:
9550172
13.

Reactivity to novelty in cognitively-impaired and cognitively-unimpaired aged rats and young rats.

Rowe WB, Spreekmeester E, Meaney MJ, Quirion R, Rochford J.

Neuroscience. 1998 Apr;83(3):669-80.

PMID:
9483551
14.

Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity.

Rowe WB, Nicot A, Sharma S, Gully D, Walker CD, Rostène WH, Meaney MJ, Quirion R.

Neuroendocrinology. 1997 Aug;66(2):75-85.

PMID:
9263204
15.

Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus.

Nicot A, Rowe WB, De Kloet ER, Betancur C, Jessop DS, Lightman SL, Quirion R, Rostène W, Bérod A.

J Neuroendocrinol. 1997 Apr;9(4):263-9.

PMID:
9147289
17.

Toxicity evaluations of L-cysteine and Procysteine, a cysteine prodrug, given once intravenously to neonatal rats.

White RD, Wilson DM, Glosson JA, Madsen DC, Rowe WB, Goldberg DI.

Toxicol Lett. 1993 Jul;69(1):15-24.

PMID:
8356563
18.

Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems.

Quirion R, Rowe WB, Lapchak PA, Araujo DM, Beaudet A.

Ann N Y Acad Sci. 1992;668:109-19. Review. No abstract available.

PMID:
1361109
19.

Medium-chain-triglyceride lipid emulsion: metabolism and tissue distribution.

Johnson RC, Young SK, Cotter R, Lin L, Rowe WB.

Am J Clin Nutr. 1990 Sep;52(3):502-8.

PMID:
2118303
20.

Competitive effects of long-chain-triglyceride emulsion on the metabolism of medium-chain-triglyceride emulsions.

Cotter R, Johnson RC, Young SK, Lin LI, Rowe WB.

Am J Clin Nutr. 1989 Oct;50(4):794-800.

PMID:
2679038
21.

Fatty acid profiles in response to soybean oil lipid emulsion infusions in essential fatty acid-deficient miniature swine.

Cotter R, Johnson R, Tumbelson M, Dexter J, Young S, Taylor CA, Cosmas F, Rowe WB, Lin L.

JPEN J Parenter Enteral Nutr. 1988 Mar-Apr;12(2):121-6.

PMID:
3129587
22.
23.

A bioengineering analysis of human muscle and joint forces in the lower limbs during running.

Harrison RN, Lees A, McCullagh PJ, Rowe WB.

J Sports Sci. 1986 Winter;4(3):201-18.

PMID:
3586113
24.

Comparison of the elimination of 10 and 20% TRAVAMULSION lipid emulsion from the blood of beagle dogs.

Cotter R, Martis L, Cosmas F, Taylor C, Young S, Rowe WB, Johnson R.

Am J Clin Nutr. 1985 May;41(5):994-1001.

PMID:
3993615
25.

Glutamine synthetase from muscle.

Rowe WB.

Methods Enzymol. 1985;113:199-212. No abstract available.

PMID:
2868384
26.

Comparison of the elimination and metabolism of 10% Travamulsion and 10% Intralipid lipid emulsion in the dog.

Cotter R, Martis L, Cosmas F, Sargent H, Taylor C, Young S, Rowe WB, Woods E.

JPEN J Parenter Enteral Nutr. 1984 Mar-Apr;8(2):140-5.

PMID:
6538910
27.

Nonlinear kinetic analysis of the elimination of lipid emulsion administered intravenously to dogs.

Cotter R, Martis L, Cosmas F, Sargent H, Taylor C, Remis W, Young S, Rowe WB, Woods E.

JPEN J Parenter Enteral Nutr. 1983 May-Jun;7(3):244-50.

PMID:
6683331
28.

Studies on the inhibition of glutamine synthetase by methionine sulfone.

Rowe WB, Meister A.

Biochemistry. 1973 Apr 10;12(8):1578-82. No abstract available.

PMID:
4144717
29.

Utilization of a cyclopentane analog of glutamate (cis-1-amino-1,3-dicarboxycyclopentane) by glutamine synthetase.

Stephani RA, Rowe WB, Gass JD, Meister A.

Biochemistry. 1972 Oct 24;11(22):4094-100. No abstract available.

PMID:
4404464
30.

Inhibition of urea biosynthesis and conversion of L-citrulline-6- 14 C to 14 C-urea by -methyl aspartic acid and -methyl aspartic acid.

Rowe WB, Miller LL.

Proc Soc Exp Biol Med. 1971 Oct;138(1):357-60. No abstract available.

PMID:
5125535
31.
32.

Identification of L-methionine S-sulfoximine as the diastereoisomer of L-methionine SR-sulfoximine that inhibits glutamine synthetase.

Manning JM, Moore S, Rowe WB, Meister A.

Biochemistry. 1969 Jun;8(6):2681-5. No abstract available.

PMID:
5799144
33.

Preparation and studies on the characterization of sheep brain glutamine synthetase.

Ronzio RA, Wilk S, Rowe WB, Meister A.

Biochemistry. 1969 Jun;8(6):2670-4. No abstract available.

PMID:
5799143
34.

Inhibition of glutamine synthetase by methionine sulfoximine. Studies on methionine sulfoximine phosphate.

Rowe WB, Ronzio RA, Meister A.

Biochemistry. 1969 Jun;8(6):2674-80. No abstract available.

PMID:
4308004
35.

Studies on the mechanism of inhibition of glutamine synthetase by methionine sulfoximine.

Ronzio RA, Rowe WB, Meister A.

Biochemistry. 1969 Mar;8(3):1066-75. No abstract available.

PMID:
4305484

Supplemental Content

Support Center